Clopi-Denk 75


  • 75 mg clopidogrel
  • Prevention and treatment of atherothrombotic events including acute coronary syndrome and thromboembolic events in atrial fibrillation
  • Proven in mono, dual and triple therapy
  • Antiplatelet inhibitor of choice in patients who do not undergo invasive strategies, but alternative medical treatment in ACS
  • Once daily - good compliance

Documented bioequivalence

Clopi-Denk 75 in comparison with the original product:

Secured By miniOrange